News

Boehringer Ingelheim has reported that the European Commission has approved Micardis (telmisartan) for the reduction of cardiovascular morbidity in patients with manifest atherothrombotic cardiovascular disease or type 2

Noveko International (Noveko) has launched its new Microban line of hand sanitizers. The hand sanitizers, formerly marketed under the Azuro brand, are now sold under the Microban brand

Boehringer Ingelheim has concluded its collaboration with Vectura by mutual consent. Under the terms of the agreement, signed in April 2006, Boehringer Ingelheim has worked with Vectura to

Sun Pharma has received tentative approval from the FDA for an Abbreviated New Drug Application (ANDA) for generic Strattera, atomoxetine hydrochloride capsules. The company said that these atomoxetine

Micardis (telmisartan) has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older, at high risk of

Stallergenes has been granted European approval to market Oralair in both adults and children through a Mutual Recognition Procedure. Oralair is an immunotherapy tablet aimed at patients suffering

Hyderabad, India-based Natco Pharma, a generic drug maker, is planing to acquire Teva. The acquisition is said to be in relation to generic Copaxone indicated for multiple sclerosis.

EMEA has validated ChemGenex Pharmaceuticals’ (ChemGenex) Marketing Authorisation Application (MAA) for omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia (CML) patients who have failed treatment with imatinib

RTS Life Science (RTS) has upgraded RTS SolidPrep with two new adaptors to support the processing of larger volume, 80ml and 120ml tubes. These larger capacity tubes support